From Research to Policy
Expedited Partner Therapy for Chlamydia
Bibliographic Data
| ID | 15744683 |
|---|---|
| Authors | Jeffrey D Klausner (0000-0002-6922-7364, University of California, San Francisco, corresponding author) |
| Year | 2005 |
| Volume | 7 |
| Issue | 10 |
| Publication date | 2005-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2005.7.10.pfor1-0510 |
| PMID | 23256937 |
| OpenAlex | W137845661 |
| Language | EN |
| Citations received | 1 |
| References cited | 1 |
In September 2000, the governor of California signed into law Senate Bill 648 which authorized physicians in California to dispense enough extra medication to patients infected with Chlamydia to treat their sex partners.1 The Centers for Disease Prevention and Control recently recommended that this practice of expedited partner therapy be a key component of the medical management of urogenital chlamydial infections.2
Chlamydia · Chlamydial infection · Disease control · Family medicine · Genitourinary medicine · Governor · Gynecology · Partner notification · Adolescent Sexual and Reproductive Health · Engineering · Medicine · Reproductive Health and Contraception · Reproductive tract infections research · Immunology · Internal Medicine · Virology
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,1 |
| Citation span | 2016 - 2016 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |